EP 1742645 A1 20070117 - COMPRESSED PHARMACEUTICAL COMPOSITIONS COMPRISING PEG AND ELECTROLYTES
Title (en)
COMPRESSED PHARMACEUTICAL COMPOSITIONS COMPRISING PEG AND ELECTROLYTES
Title (de)
KOMPRIMIERTE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT PEG UND ELEKTROLYTEN
Title (fr)
COMPOSITIONS PHARMACEUTIQUES COMPRIMEES COMPRENANT PEG ET DES ELECTROLYTES
Publication
Application
Priority
- GB 2005001555 W 20050425
- GB 0409104 A 20040423
Abstract (en)
[origin: WO2005102364A1] The invention provides a compressed pharmaceutical composition comprising polyethylene glycol of molecular weight from 2000 to 4500, wherein the polyethylene glycol makes up from 80 to 99.5% by weight of the composition, one or more electrolytes for the treatment of constipation, faecal impaction, faecal retention, intestinal gas and cramping, or flatulence; or for orthostatic lavage, colon evacuation or colon cleansing. It has been found, surprisingly, that a compressed pharmaceutical composition comprising PEG for example a solid tablet, is significantly more palatable than previously proposed compositions and is effective when administered. The compressed pharmaceutical composition of the invention comprising polyethylene glycol has been found to have a more agreeable taste and a more agreeable mouthfeel than previously proposed liquid or dry powder or granular compositions.
IPC 8 full level
A61K 31/765 (2006.01); A61K 9/20 (2006.01); A61K 9/46 (2006.01); A61K 33/00 (2006.01); A61K 33/14 (2006.01); A61K 45/06 (2006.01); A61P 1/10 (2006.01)
CPC (source: EP KR US)
A61K 9/0007 (2013.01 - EP US); A61K 9/2022 (2013.01 - EP US); A61K 31/765 (2013.01 - KR); A61K 31/77 (2013.01 - EP US); A61P 1/00 (2017.12 - EP); A61P 1/10 (2017.12 - EP); A61P 1/14 (2017.12 - EP)
Citation (search report)
See references of WO 2005102364A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR LV MK YU
DOCDB simple family (publication)
WO 2005102364 A1 20051103; AT E496626 T1 20110215; AU 2005235345 A1 20051103; AU 2005235345 B2 20110414; AU 2005235345 B8 20110512; BR PI0510175 A 20071002; CA 2561649 A1 20051103; CA 2561649 C 20141014; CN 1950097 A 20070418; DE 602005026117 D1 20110310; DK 1742645 T3 20110509; DK 2263680 T3 20141208; EP 1742645 A1 20070117; EP 1742645 B1 20110126; EP 2263680 A1 20101222; EP 2263680 B1 20140827; ES 2361816 T3 20110622; ES 2519540 T3 20141107; GB 0409104 D0 20040526; IL 178722 A0 20070211; JP 2007533719 A 20071122; KR 20070001280 A 20070103; MX PA06011906 A 20070125; NO 20064780 L 20070118; PL 1742645 T3 20110630; PL 2263680 T3 20150227; PT 1742645 E 20110429; PT 2263680 E 20141119; RU 2006137347 A 20080527; SI 1742645 T1 20110531; SI 2263680 T1 20150130; US 2007298100 A1 20071227; ZA 200608496 B 20080730
DOCDB simple family (application)
GB 2005001555 W 20050425; AT 05735983 T 20050425; AU 2005235345 A 20050425; BR PI0510175 A 20050425; CA 2561649 A 20050425; CN 200580012749 A 20050425; DE 602005026117 T 20050425; DK 05735983 T 20050425; DK 10177007 T 20050425; EP 05735983 A 20050425; EP 10177007 A 20050425; ES 05735983 T 20050425; ES 10177007 T 20050425; GB 0409104 A 20040423; IL 17872206 A 20061018; JP 2007508973 A 20050425; KR 20067024419 A 20061121; MX PA06011906 A 20050425; NO 20064780 A 20061018; PL 05735983 T 20050425; PL 10177007 T 20050425; PT 05735983 T 20050425; PT 10177007 T 20050425; RU 2006137347 A 20050425; SI 200531271 T 20050425; SI 200531914 T 20050425; US 58711405 A 20050425; ZA 200608496 A 20061011